See today's BioWorld Asia
To read the full story, subscribe or sign in.

Zai Lab nabs $761M via secondary listing in Hong Kong

Sep. 29, 2020
By David Ho
HONG KONG – U.S. listed Chinese biotech company Zai Lab Ltd. has raised $761 million in its secondary listing on the Hong Kong Stock Exchange.
BioWorld Asia Financings Cancer IPO Asia-Pacific